Recent Advances in Cardiovascular Drug Discovery (Discontinued)

Aims & Scope

Recent Advances in Cardiovascular Drug Discovery publishes review and research articles, drug clinical trial studies and guest edited thematic issues on cardiovascular drug discovery . The scope covers but is not limited to , medicinal chemistry, pharmacology, genomics, biochemistry, ...read more

  • ISSN (Print): 1574-8901
  • ISSN (Online): 2212-3962
  • Volume: 10
  • Issues: 2, 2015
Recent Advances in Cardiovascular Drug Discovery (Discontinued)

Volume 10, Issue 1, 2015


Editorial
Meet Our Editorial Board Member

Pp: 1-1

Author(s): Ryuichi Morishita

DOI: 10.2174/157489011001160111164611

Hypertension in Type 2 Diabetes Mellitus: Do We Need to Redefine the Role of Sulfonylureas?

Pp: 4-9

Author(s): Devindra Sehra and Sudhish Sehra

DOI: 10.2174/157489011001160111154536

Basic and Clinical Research Against Advanced Glycation End Products (AGEs): New Compounds to Tackle Cardiovascular Disease and Diabetic Complications

Pp: 10-33

Author(s): Antonio Nenna, Cristiano Spadaccio, Mario Lusini, Luca Ulianich, Massimo Chello and Francesco Nappi

DOI: 10.2174/1574890110666151104120039

The Challenges of Blood Pressure Control in Dialysis Patients

Pp: 34-59

Author(s): Vito M. Campese and Ravi Lakdawala

DOI: 10.2174/1574890110666151116144725

NOAC or warfarin for Atrial Fibrillation: does time in therapeutic range matter?

Pp: 60-64

Author(s): Ioannis Merinopoulos, Paul Venables, Isobel Chalmers and Vassilios Vassiliou

DOI: 10.2174/1574890110666150914121856

Combination of Vasopressin –Epinephrine as a Novel Candidate in Patients with Cardiac Arrest

Pp: 65-69

Author(s): Nasim Ghafourian, Nader H. Maniae, Morovat Taherikalani, Maryam Mehrazi, Mahnaz Hossieni, Firouzeh Valian, Shahriar Karami, Yazdan Rahmatian and Nader Tavakoli

DOI: 10.2174/157489011001160111163856

Cardiovascular Implantable Electronic Device Infections: Risk Scoring and Role of Antibiotic Envelope in Prevention

Pp: 70-76

Author(s): Nasir Shariff, Tauseef Akthar, Eathar Razak, Nathan Segerson and David Schwartzman

DOI: 10.2174/1574890110666151104120207